SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company. Its pipeline includes products in various stages of clinical and non-clinical development. It focuses on proven pharmaceutical products in the cardiovascular and infectious disease therapeutic areas.

$5.21
As of 06/21/2021     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  11/17/2017
Outstanding shares:  27,355,454
Average volume:  58,988
Market cap:   $141,974,806
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    810648105
ISIN:        US8106481059
Sedol:      BYX2Z16

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   1.89
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%